Ticagrelor vs. Prasugrel Effects on Infarct Size

NCT02507323 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped collaborator withdrew the study

Conditions

Cardiovascular Disease

Interventions

DRUG: ticagrelor
DRUG: prasugrel
DRUG: Placebo

Sponsor

Yochai Birnbaum

Collaborators

[object Object]